| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $76.5M | +2.8% | +4.6% |
| R&D Expense | $12.1M | +0.3% | +0.1% |
| SG&A Expense | $12.1M | +2.8% | +5.6% |
| Operating Income | $7.6M | +28.6% | +16.5% |
| Pre-tax Income | $8.3M | +20.2% | +10.3% |
| Income Tax | $2.2M | +46.5% | +23.5% |
| Net Income | $6.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $53.5M | +2.8% | -6.9% |
| Accounts Receivable | $27.7M | +2.8% | +5.1% |
| Current Assets | $147.6M | +2.2% | +1.3% |
| Total Assets | $499.9M | -0.0% | -0.6% |
| Current Liabilities | $112.5M | -2.5% | +1.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $50.1M | — | — |
| Capital Expenditures | $3.5M | — | — |
| Investing Cash Flow | -$27.0M | — | — |
| Financing Cash Flow | -$29.0M | — | — |
| Free Cash Flow | $46.6M | — | — |
| +12.9% |
| +6.3% |
| EPS (Basic) | $0.20 | +11.1% | +5.3% |
| EPS (Diluted) | $0.20 | +11.1% | +5.3% |
| $349.2M |
| -0.4% |
| -1.8% |